OpGen, Inc. Profile Avatar - Palmy Investing

OpGen, Inc.

OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for t…

Medical - Diagnostics & Research
US, Rockville [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

OpGen, Inc. has no acquisition track records yet.

M&A Deals · History

OpGen, Inc. has no acquisition track records yet.

End of OPGN's Analysis
CIK: 1293818 CUSIP: 68373L307 ISIN: US68373L4068 LEI: - UEI: -
Secondary Listings
OPGN has no secondary listings inside our databases.